Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 37Unknown 4Withdrawn 3Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Breast Neoplasms 35Lymphoma, Large B-Cell, Diffuse 22Sarcoma 19Lymphoma 19Carcinoma, Hepatocellular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Non-Hodgkin 9Hodgkin Disease 9Multiple Myeloma 8Leukemia 8Neuroblastoma 6Liver Neoplasms 6Lymphoma, Follicular 5Immunoblastic Lymphadenopathy 5Ovarian Neoplasms 4Lymphoma, T-Cell, Peripheral 4Lymphoma, Mantle-Cell 4Triple Negative Breast Neoplasms 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Neoplasms, Plasma Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Liposarcoma 3Leiomyosarcoma 3Chondrosarcoma 3Burkitt Lymphoma 3Wilms Tumor 2Rhabdomyosarcoma 2

Interventions

Cyclophosphamide 17Rituximab 14Cytarabine 9Peripheral Blood Stem Cell Transplantation 7Melphalan 7Etoposide 7Filgrastim 6Dexamethasone 6fludarabine phosphate 5fludarabine 5Radiotherapy 5Cyclosporine 5Carmustine 5ibrutinib 4Vincristine 4Prednisone 4Lenalidomide 4Doxorubicin 4Bortezomib 4Sensitivity and Specificity 3R-CHOP protocol 3Mycophenolic Acid 3Interferon-alpha 3Indium 3Cisplatin 3Busulfan 3Bendamustine Hydrochloride 3Antilymphocyte Serum 3Antigens, CD19 3sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Mantle-Cell × Doxorubicin × Clear all
NCT00209209 2017-03-07

MCLelderly

European Mantle Cell Lymphoma Network

Phase 3 Unknown
570 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT00028717 2013-09-17

Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
400 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT00209222 2012-09-10

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

European Mantle Cell Lymphoma Network

Phase 3 Unknown
360 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT00946374 2009-07-27

HD-MCL2003

Heidelberg University

Phase 2 Unknown
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡